SCHEMBL5451788

SCHEMBL5451788

CC(C)(C)OC(=O)C12CNCC(C1)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31172828 0.85
SCHEMBL6216318 0.83
SCHEMBL15532995 0.75
SCHEMBL31172812 0.74
SCHEMBL31172959 0.73
SCHEMBL585092 0.71 CYP17A1 (0.36)
SCHEMBL20586469 0.70 DDB1 (0.33)
SCHEMBL14249653 0.70
SCHEMBL31173066 0.70
SCHEMBL31172934 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118908979-A SIRT3 novel inhibitor and application thereof in AML therapeutic drug 深圳大学 2024-11-08 CN disclosed
EP-3805234-B1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF GUANGZHOU HENOVCOM BIOSCIENCE CO LTD (CN) 2024-09-04 EP disclosed
US-11679108-B2 Aromatic heterocyclic compound, and pharmaceutical composition and use thereof GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD. (CN) 2023-06-20 US disclosed
US-20220088008-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD. (CN) 2022-03-24 US disclosed
EP-3805234-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF Guangzhou Henovcom Bioscience Co., Ltd. (CN) 2021-04-14 EP disclosed
US-20070225492-A1 3,6-Diazabicyclo[3.1.1]Heptane Derivatives with Analgesic Activity UNIVERSITA' DEGLI STUDI DI MILANO (IT) 2007-09-27 US disclosed